期刊文献+

诱导型一氧化氮合酶抑制剂对胃癌MFC细胞增殖与凋亡的影响 被引量:3

Effect of aminoguanidine on proliferation and apoptosis of stomach cancer MFCs in mice
原文传递
导出
摘要 目的研究诱导型一氧化氮合酶(iNOS)选择性抑制剂氨基胍(AG)对鼠胃癌MFC细胞增殖和凋亡的影响。方法将40只MFC胃癌皮下接种模型小鼠随机分成4组对照组(等体积生理盐水)、丝裂霉素组(MMC,每周注射2次,每次0.7mg/kg)、AG组(150mg·kg-1·d-1)和MMC加AG组。均采用腹腔内注射给药法,持续14d;停药后24h处死动物。应用Greiss反应法测定荷瘤动物血浆中一氧化氮(NO)量;剥离肿瘤,称重并计算抑瘤率;应用免疫组织化学法检测肿瘤细胞中增殖细胞核抗原(PCNA)的表达,TdT介导的dUTP缺口末端标记(TUNEL)法检测肿瘤细胞的凋亡,透射电镜观察凋亡细胞的超微结构。结果AG显著降低荷瘤小鼠血浆中NO的合成,明显抑制肿瘤的生长,抑瘤率为47.1%,与对照组比较,P<0.01。AG组的肿瘤细胞PCNA表达值为25.2±3.6,MMC加AG组为22.0±3.6,明显低于对照组的82.0±3.6(P<0.01);但凋亡指数未见下降,电镜下亦未见典型的细胞凋亡形态学变化。结论AG通过抑制肿瘤组织中NO的产生而抑制肿瘤生长,但并未促进肿瘤细胞凋亡。 Objective To investigate the effects of aminoguanidine (AG),a selective inhibitor of inducible nitric oxide synthase on proliferation and apoptosis of MFC stomach cancer in mice. Methods The mice stomach carcinoma cell line MFC was implanted subcutaneously in kunming mice. Mice were randomly divided into 4 groups: control group (saline solution),MMC group (mitomycin,twice a week 0.7 mg/kg ),AG group (AG,150 mg·kg-1·d-1) and combined treatment of both MMC and AG group. All drugs were given by intraperitoneal injection. The mice were sacrificed after 2 weeks and the tumors were processed for histological examination. In addition,sera were collected and nitrite levels were tested using Greiss assay. The expression of proliferating cell nuclear antigen (PCNA) in tumors was detected by immunohistochemical method and apoptosis in tumors was measured by TdT mediated biotinyated dUTP nick end labeling (TUNEL) method. The ultrastructural features of apoptosis cells were observed under electromicroscope. Results Compared with the negative control group,the growth of the orthotopically implanted tumor was significantly inhibited by AG and the inhibitory rate was 47.1%. Expression of PCNA in AG treated group was lower than that in the control group,but no significant difference in apoptosis index (AI) was found. Typical morphological changes of apoptosis in tumor cells were not observed in AG treated group. Conclusion AG can significantly inhibit tumor growth by inhibiting the production of NO,but can not promote the apoptosis of MFC cells.
出处 《中华胃肠外科杂志》 CAS 2004年第6期496-498,共3页 Chinese Journal of Gastrointestinal Surgery
基金 吉林省自然科学发展基金资助项目(20010536)
关键词 诱导型一氧化氮合酶抑制剂 胃癌 MFC细胞增殖 凋亡 Stomach neoplasm Aminoguanidine Proliferating cell nuclear antigen Apoptosis
  • 相关文献

参考文献8

  • 1王旭,王广义.人胃癌VEGF和NOS的表达及其相关性[J].中国肿瘤临床,2003,30(2):77-80. 被引量:4
  • 2Koh E,Noh SH,Lee YD,et al. Differential expression of nitric oxide synthase in human stomach cancer. Cancer Letters, 1999, 146:173-180.
  • 3Ambs S,Merriam WG,Bennett WP,et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res, 1998, 58: 334-341.
  • 4Thomsen LL,Scott JM,Topley P,et al. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo:studies with 1400W,a novel inhibitor. Cancer Res, 1997, 57:3300-3304.
  • 5Juang SH,Xie K,Xu L,et al. Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene. Hum Gene Ther,1998, 9:845-854.
  • 6Salvucci O,Carsana M,Bersani I,et al. Antiapoptotic role of endogenous nitric oxide in human melanoma cells,Cancer Res, 2001, 61:318-326.
  • 7Forrester K,Ambs S,Lupold SE,et al. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc Natl Acad Sci USA,1996,93:2442-2444.
  • 8Ho YS,Wang YJ,Lin JK. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol Carcinog,1996,16:20-24.

二级参考文献15

  • 1[1]Lee JC, Chow NH, Wang ST, et al. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients[J]. EurJ Cancer, 2000, 36(6): 748~753
  • 2[2]Mattern J, Koomagi R, Volm M. Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density[J]. Anticancer Res, 1997, 17: 2249~2252
  • 3[3]Bruns CJ, Liu W, Davis DW, et al. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastasis[J]. Cancer, 2000, 89(3): 488~499
  • 4[4]Ambs S, Merriam WG, Ogunfusika MO, et al. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells[J]. Nat-Med, 1998, 4(12): 1371~1376
  • 5[5]Wink DA, Vodovotz Y, Laval J, et al. The multifaceted roles of nitric oxide in cancer[J]. Carcinogenesis, 1998, 19(5): 711~721
  • 6[6]Gallo O, Masini E, Morbidelli L, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer[J]. J Nat Cancer Inst, 1998, 90:587~596
  • 7[7]Jozkowicz A, Pankiewicz J, Pulak J, et al. Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells [J]. Acta Biochim Pol, 1999, 46(3): 703~715
  • 8[8]Scalia R, Booth G, Lefer DJ. Vascular endothelial growth factor attenuates leukocyte-endothelium interaction during acute endothelial dysfunction: essential role of endothdium-derived nitric oxide[J]. FASEB J, 1999, 13(9): 1039~1046
  • 9[9]Hood JD, Meininger CJ, Ziche M, et al. VEGF upregulates ecNOS message, protein and NO production in human endothelial cells[J]. Am J Physiol, 1998, 274:H1054~1058
  • 10[10]Dulak J, Jozkowicz A, Dembinska-Kiec A, et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth musde cells[J]. Arterioscler Thromb Vasc Biol, 2000, 20(3): 659~666

共引文献3

同被引文献25

  • 1蒋跃绒,殷惠军,陈可冀.赤芍801研究现状[J].中国中西医结合杂志,2004,24(8):760-763. 被引量:31
  • 2杨继金,朱永法.大白鼠转移性肝癌模型的制作[J].中华放射学杂志,1993,27(2):122-123. 被引量:43
  • 3瞿雪梅,顾伟,胡佳娜,董惠娟.大鼠移植性肝癌模型血管介入的护理[J].实验动物科学与管理,2005,22(2):56-57. 被引量:4
  • 4董兰兰,袁响林.乏氧诱导因子促进肿瘤侵袭转移的研究进展[J].中国肿瘤生物治疗杂志,2006,13(5):390-392. 被引量:7
  • 5Calmels S, Hainaut P, Ohshima H. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein[J].Cancer Res,1997,57:3365.
  • 6Rittling S R,Chambers A F. Role of osteopontin in tumour progression[J].Br J Cancer,2004,90(10):1877.
  • 7邹益友 冯德云 等.一氧化氮合酶mRNA在胃癌细胞内的表达[J].中华消化杂志,1999,19(3):213-213.
  • 8赵素欣 李爱华.肝脏介入术后的护理[J].中国临床医药研究杂志,2003,87:51-52.
  • 9Fukumura D,Yuan F,Endo M, et al.. Role of nitric oxide in tumor microciCulation. Blood flow, vascular permeability, and leukocyteendothelial interactions[ J ]. Am J Pathol, 1997 ; 150:713-725
  • 10Krocke KD, Fehsel K, Kold-Bachofen V. Inducible nitric oxide synthase in human disease [ J ]. Clin Exp Immunol, 1998 ; 113 (2) : 147

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部